Trials / No Longer Available
No Longer AvailableNCT04381091
Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Santhera Pharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Expanded Access Program for Idebenone in Patients with Leber's Hereditary Optic Neuropathy who completed the LEROS Study
Detailed description
see above
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Idebenone 150 MG Oral Tablet | idebenone 900 mg/day |
Timeline
- First posted
- 2020-05-08
- Last updated
- 2023-04-21
Source: ClinicalTrials.gov record NCT04381091. Inclusion in this directory is not an endorsement.